Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -99,059 | -74,363 | -48,133 | -31,148 | -14,978 |
| Depreciation Amortization | 1,798 | 1,127 | 566 | 3,271 | 197 |
| Accounts payable and accrued liabilities | 2,479 | 5,385 | 4,829 | 2,045 | -1,272 |
| Other Working Capital | 627 | 4,545 | 4,663 | 1,529 | -1,263 |
| Other Operating Activity | 14,315 | 7,560 | 4,349 | 7,855 | 2,348 |
| Operating Cash Flow | $-79,840 | $-55,746 | $-33,726 | $-16,448 | $-14,968 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,077 | -3,280 | -181 | -63 | -51 |
| Purchase Of Investment | -35,169 | -46,872 | -95,376 | N/A | N/A |
| Sale Of Investment | 58,346 | 59,534 | 22,239 | N/A | N/A |
| Investing Cash Flow | $18,100 | $9,382 | $-73,318 | $-63 | $-51 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 122,853 | 15,000 | 3,000 |
| Common Stock Issued | 168,625 | 51,838 | 128 | 71,870 | 6 |
| Dividend Paid | N/A | N/A | N/A | N/A | -130 |
| Other Financing Activity | 0 | 0 | 0 | -3,635 | 0 |
| Financing Cash Flow | $168,625 | $51,838 | $122,981 | $83,235 | $2,876 |
| Beginning Cash Position | 91,060 | 85,586 | 69,649 | 2,925 | 15,068 |
| End Cash Position | 197,945 | 91,060 | 85,586 | 69,649 | 2,925 |
| Net Cash Flow | $106,885 | $5,474 | $15,937 | $66,724 | $-12,143 |
| Free Cash Flow | |||||
| Operating Cash Flow | -79,840 | -55,746 | -33,726 | -16,448 | -14,968 |
| Capital Expenditure | -5,077 | -3,280 | -181 | -63 | -51 |
| Free Cash Flow | -84,917 | -59,026 | -33,907 | -16,511 | -15,019 |